Skip to main content
MiMedx Group, Inc. (MDXG)
NASDAQ: MDXG · Real-Time Price · USD
9.28
+0.22 (2.37%)
Nov 21, 2024, 1:32 PM EST - Market open

MiMedx Group Revenue

MiMedx Group had revenue of $84.06M in the quarter ending September 30, 2024, with 2.87% growth. This brings the company's revenue in the last twelve months to $342.80M, up 10.93% year-over-year. In the year 2023, MiMedx Group had annual revenue of $321.48M with 20.03% growth.

Revenue (ttm)
$342.80M
Revenue Growth
+10.93%
P/S Ratio
3.70
Revenue / Employee
$383,021
Employees
895
Market Cap
1.36B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023321.48M53.64M20.03%
Dec 31, 2022267.84M25.82M10.67%
Dec 31, 2021242.02M-6.22M-2.50%
Dec 31, 2020248.23M-51.02M-17.05%
Dec 31, 2019299.26M-59.86M-16.67%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Evolent Health 2.46B
Myriad Genetics 823.60M
U.S. Physical Therapy 639.06M
Alphatec Holdings 572.74M
Schrödinger 193.35M
Day One Biopharmaceuticals 101.95M
Ocular Therapeutix 61.44M
ARS Pharmaceuticals 2.57M
Revenue Rankings

MDXG News

More News